Sharps Technology Inc (STSS) - News Archive

Sharps Technology, Inc. Closes Successful $20 Million Public Offering Amidst Strategic Repositioning EffortsNew York, January 29, 2025 Sharps Technology, Inc. (NASDAQ: STSS), a forward-thinking medical device and pharma...

In a bold move signaling its commitment to growth and expansion, Sharps Technology, Inc. (NASDAQ: STSS), an emerging player in the medical device and pharmaceutical packaging sphere, announced on January 28, 2025, that...

Revisiting Sharps Technology’s Strategic Path Amidst Manufacturing Expansion and Financial ChallengesBy December 5, 2024 – New York, NYIn a recent shareholder letter, Robert Hayes, the CEO of Sharps Technology, Inc. (NA...

In a move aimed at enhancing shareholder value and bolstering its market presence, Sharps Technology, Inc. (NASDAQ: STSS) has announced an upcoming one-for-22 reverse stock split of its common stock, set to take effect...

In a strategic move poised to bolster its market position and strengthen shareholder value, Sharps Technology, Inc. (NASDAQ: STSS) has called upon its shareholders to cast their votes in favor of a key proposal before t...

In a significant development for the medical device and pharmaceutical packaging sector, Sharps Technology, Inc. (NASDAQ: STSS) has secured a $3.5 million bridge financing, a move that is not just timely but crucial for...

Sharps Technology, a notable player in the medical products sector, has recently announced a pivotal five-year sales agreement with a leading American medical products company. This partnership is poised to generate ove...

Dear Shareholders,I hope this letter finds you well. As the CEO of Sharps Technology, I am writing to urge your support and approval on three vital proposals that are crucial to the continued growth and success of our c...

In an exciting development for the medical industry, Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies, Sharps Technology, has recently issued purchase orders for an impressive 1 million unit...

Amidst recent funding success, all shareholders of Sharps Technology Inc. who were on record as of May 17, 2024, are now eligible to vote on a significant decision impacting the company s future. This announcement comes...

Sharps Technology Strengthens Position in Pre-Fillable Syringe Industry with Key Acquisitions and Worldwide Sales AgreementIn a significant move to solidify its presence in the pre-fillable syringe (PFS) market, Sharps...

Sharps Technology s SC Asset Purchase and $200 Million Syringe Sales Agreement: A New Era in U.S. Prefillable Syringe Production Sharps Technology, an innovative leader in the production of advanced drug delivery system...

Sharps Technology, a leading player in the medical technology industry, is making significant strides in expanding its manufacturing capacity and global reach. In a recent development, the company signed a 5-year, $200...

In a groundbreaking move, Sharps Technology and Roncadelle Operations have recently announced a worldwide sales and distribution agreement for their innovative portfolio of safe technology drug delivery systems. This co...

In a significant development for the healthcare industry, Sharps Technology, a leading provider of innovative medical devices, has made its entry into the Latin American market. The company has received its initial orde...

The healthcare industry continues to witness significant advancements and innovative solutions aimed at improving patient care. In this pursuit, Sharps Technology and Roncadelle have recently formed a strategic collabor...

Sharps Technology and Roncadelle Operations Forge Alliance to Revolutionize Safe Drug Delivery Systems GloballyIn a groundbreaking move, Sharps Technology and Roncadelle Operations have recently announced their collabor...

Sharps Technology Raises $5.6 Million Through Registered Direct and Private PlacementNEW YORK, Sept. 27, 2023 - Sharps Technology, Inc. (NASDAQ: STSS and STSSW), a leading medical device and pharmaceutical packaging com...